Optimum combination therapy regimens for HIV/HCV infection.

about

Sofosbuvir and ribavirin in acute hepatitis C-infected patient with decompensated cirrhosis.

P2860

Q37606123-9868B56E-06C8-4A01-9716-41947B26C016

P2860

Optimum combination therapy regimens for HIV/HCV infection.

Item

http://www.wikidata.org/entity/Q38715477

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Optimum combination therapy regimens for HIV/HCV infection.

@en

type

Item

label

Optimum combination therapy regimens for HIV/HCV infection.

@en

prefLabel

Optimum combination therapy regimens for HIV/HCV infection.

@en

P1476

Optimum combination therapy regimens for HIV/HCV infection.

@en

P2093

David Rey

http://www.w3.org/2001/XMLSchema#string

Lionel Piroth

http://www.w3.org/2001/XMLSchema#string

Patrice Muret

http://www.w3.org/2001/XMLSchema#string

P2860

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

Sofosbuvir, a Significant Paradigm Change in HCV Treatment

The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment

Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?

Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients

Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa.

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.

P304

299-309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2016.1147952

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292305060

http://www.w3.org/2001/XMLSchema#string

P698

26822803

http://www.w3.org/2001/XMLSchema#string

Optimum combination therapy regimens for HIV/HCV infection.

about

P2860

P2860

Optimum combination therapy regimens for HIV/HCV infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698